NEW YORK (GenomeWeb) – Exact Sciences and the University of Texas MD Anderson Cancer Center today announced an agreement to develop and commercialize blood-based screening and diagnostic tools for the early detection of lung cancer. 

Under the terms of the deal, the partners will develop a lung cancer screening test to determine the need for low-dose computed tomography (LDCT). The partners said such a test could be used to screen about 11 million Americans considered to be high-risk smokers and former smokers. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.